Singapore markets closed

Ultimovacs ASA (ULTI.OL)

Oslo - Oslo Delayed price. Currency in NOK
Add to watchlist
7.020.00 (0.00%)
As of 12:13PM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
123,062
123,834
95,175
96,735
64,660
-
Selling general and administrative
7,465
6,476
9,246
5,061
3,978
-
Total operating expenses
191,966
215,733
183,629
163,832
124,146
-
Operating income or loss
-193,619
-215,733
-183,629
-163,832
-124,146
-
Interest expense
-
-
-
333
240
263
Income before tax
-177,880
-189,239
-167,792
-164,722
-120,552
-
Income tax expense
0
0
0
0
0
-
Income from continuing operations
-177,880
-189,239
-167,792
-164,722
-120,552
-
Net income
-177,880
-189,239
-167,792
-164,722
-120,552
-
Net income available to common shareholders
-177,880
-189,239
-167,792
-164,722
-120,552
-
Basic EPS
-6.00
-
-4.90
-5.10
-4.00
-2.70
Diluted EPS
-6.00
-
-4.90
-5.10
-4.00
-2.70
Basic average shares
34,374
-
34,247
32,373
30,260
22,927
Diluted average shares
34,374
-
34,247
32,373
30,260
22,927